… treatment with stereotactic ablative radiation therapy or standard therapy among patients with
… The model derived transition probabilities from Stereotactic Ablative Radiation therapy for …

… patients with a controlled primary malignancy and 1-5 metastatic lesions, with all metastases
amenable to stereotactic ablative radiotherapy … palliative standard-of-care (SOC) treatments …

… ESTRO/European Organization for Research and Treatment of Cancer (EORTC) in an …
patient populations eligible for ongoing clinical trials evaluating stereotactic ablative radiotherapy (…

… of stereotactic ablative radiation therapy (SABR) to the primary tumor for patients with …
Over the last 2 decades, stereotactic ablative radiotherapy (SABR) has rapidly emerged as an …

… We evaluated the effect of stereotactic ablative radiation therapy (… patient had deteriorating
health while on axitinib as third-line systemic therapy and opted for palliative care/hospice 8 …

… to support patients referred for palliative radiotherapy. Many … Stereotactic ablative
radiotherapy if oligometastatic … Separation surgery and stereotactic ablative radiotherapy (SABR …

… of Oligometastatic Disease (SABR-COMET) trial enrolled 99 patients who had controlled …
Patients were randomized in a 1:2 ratio between standard of care (SOC) palliative treatments (…

… ablative radiotherapy for oligometastases have shown similarly low toxicity with no treatment-…
palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, …

… For the patients treated across 3-5 weeks, the treatment delivery period spanned a much
longer timeframe than the 1–2-week treatments typically seen in the palliative setting, which …

… progression, with palliative radiotherapy reserved for sites of symptomatic disease.
Stereotactic ablative radiotherapy (SABR) has shown promise in the treatment of oligometastatic …